Chemoinformaics analysis of 2,3-Di-O-methyl-L-arabinose
Molecular Weight | 178.184 | nRot | 6 |
Heavy Atom Molecular Weight | 164.072 | nRig | 1 |
Exact Molecular Weight | 178.084 | nRing | 0 |
Solubility: LogS | 0.413 | nHRing | 0 |
Solubility: LogP | -1.537 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 25.0351 |
nHD | 2 | BPOL | 18.3849 |
QED | 0.488 |
Synth | 4.035 |
Natural Product Likeliness | 1.955 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.025 |
HIA | 0.421 |
CACO-2 | -4.961 |
MDCK | 0.000587402 |
BBB | 0.109 |
PPB | 0.259498 |
VDSS | 0.481 |
FU | 0.773192 |
CYP1A2-inh | 0.008 |
CYP1A2-sub | 0.219 |
CYP2c19-inh | 0.008 |
CYP2c19-sub | 0.248 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.032 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.115 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.126 |
CL | 5.084 |
T12 | 0.745 |
hERG | 0.071 |
Ames | 0.12 |
ROA | 0.008 |
SkinSen | 0.721 |
Carcinogencity | 0.022 |
EI | 0.952 |
Respiratory | 0.029 |
NR-Aromatase | 0.07 |
Antiviral | No |
Prediction | 0.931023 |